Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis2018-01-17T17:00:56-05:00
What went wrong in the natalizumab trials? What went wrong in the natalizumab trials?2018-01-17T16:59:56-05:00
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab2018-01-17T16:59:56-05:00
